Barriers to Care for Pediatric Patients with Obesity

Bodepudi, Sreevidya; Hinds, Malikiya; Northam, Kayla; Reilly-Harrington, Noreen A.; Stanford, Fatima Cody

doi:10.3390/life14070884

Cited by 2 publications

References 84 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Treatment of obesity in US children and adolescents before and after the AAP guidelines

Rodriguez,

Do,

Gratzl

et al. 2024

Preprint

View full text Add to dashboard Cite

Importance: The American Academy of Pediatrics (AAP) published new comprehensive guidelines for childhood obesity treatment, including pharmacotherapy. However, changes in treatment patterns following these guidelines remain unknown. Objective: To assess changes in childhood and adolescent obesity treatment following the new AAP guidelines. Design: Using Truveta electronic health record (EHR) data, this cohort study analyzed outpatient visits between January 2021 and June 2024 for children (age 8-11) and adolescents (age 12-17) with obesity and no evidence of type 2 diabetes (T2D). For patients with multiple visits, one visit was randomly selected. Patients without a recent history of specific obesity treatments were followed for evidence of obesity treatment at or following their visit, including nutrition referral within 14 days or nutrition counseling within 90 days, and, separately, pharmacotherapy prescriptions for weight management (on- or off-label) within 14 days. Interrupted time series models were used to compare differences in nutrition counseling or referral and pharmacotherapy before versus after the AAP guidelines were released. Setting: Clinical and prescribing data from EHRs from a collective of US health systems. Participants: 329,357 patients aged 8 to 17 with an outpatient office visit, a BMI percentile indicating obesity, and no T2D diagnosis. Exposure: Release of the AAP guidelines in January 2023. Main Outcomes and Measures: Evidence of obesity treatment at or following the eligible visit with (1) nutrition referral or counseling, and (2) pharmacotherapy. Results: The study population of 329,581 patients included 120,734 (36.6%) children and 208,847 (63.4%) adolescents. The mean (SD) BMI percentile was 97.4 (1.6), with 119,864 (36.4%) having severe obesity (class 2 or 3). Overall, a minority of patients without a recent history of obesity treatment had evidence of nutrition referral or counseling (4.0%) or pharmacotherapy (0.4%) during or shortly after their visit. Following the AAP guidelines, indicators of both immediate (odds ratio [95% CI]: 1.38 [1.08-1.75]) and gradual monthly changes (1.06 [1.04-1.08]) were observed for pharmacotherapy use. An immediate change in nutrition counseling and referral was observed following guidelines (1.34 [1.24-1.45]), but no additional gradual monthly changes were observed (1.0 [0.99-1.01]). Conclusions and Relevance: While nutrition counseling or referral and pharmacotherapy use increased, overall rates of obesity treatment remained low.

show abstract

Treatment of obesity in US children and adolescents before and after the AAP guidelines

Rodriguez,

Do,

Gratzl

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Advances in pediatrics in 2023: choices in allergy, analgesia, cardiology, endocrinology, gastroenterology, genetics, global health, hematology, infectious diseases, neonatology, neurology, pulmonology

Caffarelli,

Santamaria,

Bozzola

et al. 2024

Ital J Pediatr

View full text Add to dashboard Cite

In the last year, there have been many remarkable articles published in the Italian Journal of Pediatrics. This review highlights papers that can be potentially helpful in healthcare practice among the most cited or accessed papers on the journal website. We have chosen key articles on allergy, analgesics, cardiology, endocrinology, gastroenterology, genetics, global health, infectious diseases, neonatology, neurology and pulmonology. Advances in understanding risk factors, mechanisms, diagnosis, treatment options and prevention of pediatric diseases have been discussed and in the context of the subsequent steps. We think that progresses achieved in 2023 will have a significant impact on the management of diseases in childhood.

show abstract

Barriers to Care for Pediatric Patients with Obesity

Cited by 2 publications

References 84 publications

Treatment of obesity in US children and adolescents before and after the AAP guidelines

Treatment of obesity in US children and adolescents before and after the AAP guidelines

Advances in pediatrics in 2023: choices in allergy, analgesia, cardiology, endocrinology, gastroenterology, genetics, global health, hematology, infectious diseases, neonatology, neurology, pulmonology

Contact Info

Product

Resources

About